Xynomic Pharmaceuticals Holdings Stock Price, News & Analysis

XYNO OTC

Company Description

Xynomic Pharmaceuticals Holdings (OTC: XYNO) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

This page provides a comprehensive overview of XYNO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

46.3M

Shares outstanding

Latest News

View All

June 17, 2021

—

Xynomic Closed a Short Form Merger for "Going Private" Transaction

acquisition

Xynomic Pharmaceuticals Holdings has 1 recent news article. Key topics include acquisition. View all XYNO news →

SEC Filings

View All

No SEC filings available for XYNO.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

XYNO Company Profile & Sector Positioning

Xynomic Pharmaceuticals Holdings (XYNO) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.